Moody Aldrich Partners LLC Aerie Pharmaceuticals Inc Transaction History

Moody Aldrich Partners LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 26, 2019	SELL	$28.97 - $48.21 $1.07 Million - $1.78 Million	-36,980 Closed	0 $0
Q1 2019 May 03, 2019	BUY	$36.32 - $49.25 $1.34 Million - $1.82 Million	36,980 New	36,980 $1.76 Million
Q4 2018 Feb 12, 2019	SELL	$33.0 - $60.04 $2.53 Million - $4.6 Million	-76,537 Closed	0 $0
Q3 2018 Oct 31, 2018	BUY	$56.15 - $73.9 $667,174 - $878,079	11,882 Added 18.38%	76,537 $4.71 Million
Q2 2018 Aug 13, 2018	BUY	$47.85 - $70.45 $1.12 Million - $1.66 Million	23,498 Added 57.09%	64,655 $4.37 Million
Q1 2018 Apr 26, 2018	BUY	$51.15 - $61.0 $470,631 - $561,261	9,201 Added 28.79%	41,157 $2.23 Million
Q4 2017 Jan 31, 2018	BUY	$50.85 - $65.1 $530,365 - $678,992	10,430 Added 48.45%	31,956 $1.91 Million
Q3 2017 Nov 13, 2017	BUY	$48.6 - $60.1 $1.05 Million - $1.29 Million	21,526	21,526 $1.05 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Moody Aldrich Partners LLC with notifications on news.